✦ LIBER ✦

Success for oral antisense therapy

✍ Scribed by Hillary E Sussman

Book ID: 114384411
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 60 KB
Volume: 8
Category: Article
ISSN: 1359-6446
DOI: 10.1016/s1359-6446(03)02744-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful infliximab therapy for oral C

Successful infliximab therapy for oral Crohn's disease

✍ H. Cardoso; A.C. Nunes; F. Carneiro; F. Tavarela Veloso 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Antisense therapy for cancer

✍ Gleave, Martin E.; Monia, Brett P. 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 462 KB

Antisense therapy for lymphomas

✍ Finbarr E. Cotter 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

  antisense; BCL-2; apoptosis; lymphoma 'gene silencing', by synthetic oligonucleotides, as a therapeutic tool. In the field of lymphomas obvious targets include follicular lymphoma with the t(14;18) translocation, deregulated expression of the BCL-2 gene, chemoresistance and subsequent prot

Antisense therapy for melanoma

✍ Ernest C. Borden 📂 Article 📅 2001 🏛 Current Science Inc. 🌐 English ⚖ 75 KB

Antisense therapy for cancer

✍ F.E Cotter 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Trial watch: Phase III success for Bioge

Trial watch: Phase III success for Biogen's oral multiple sclerosis therapy

📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB